APVO

0.40611.88%
BL

Barbara Lopez Kunz

Independent Director

Ms. Barbara Lopez Kunz is Chief Executive Officer of dMed Company Limited. Ms. Kunz has been an Independent Director of Aptevo Therapeutics Inc. since August 1, 2016. She served as the Global Chief Executive of the Drug Information Association until March 2023. Ms. Kunz served as the President of the Health and Life Sciences Global Business at Battelle Memorial Institute from January 2007 to March 2013. She was responsible for the relationship between Battelle and the United States Department of Health and Human Services agencies, such as the Centers for Disease Control, the National Institutes of Health, the National Institute for Allergy and Infectious Diseases and the National Institute of Environment Health Sciences, as well as the Environmental Protection Agency. She joined Battelle from Fisher Scientific International, where she served as Senior Vice President and General Manager for Fisher Biosciences. From August 2003 to December 2007, she worked as Senior Vice President /General Manager for Thermo Fisher Scientific’s Fisher Biosciences and led the Latin America regional business from January 2000 to July 2003 at Uniqema, a private company acquired by Croda International plc in 2006. She served as the Chairman of BioOhio, Inc. and serves as its Trustee. She serves as a Trustee at Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Ms. Kunz also worked as Head of Strategy/M&A of Dupont from 1997 to 1998 and was the Global VP for the Enterprise Business Group of Imperial Chemical Industries (now AstraZeneca/Croda) from 1993 to 1997. Ms. Kunz serves as Chair of the Board of Directors of Children’s National Health System Research Institute. She has MBA coursework at Cleveland State University. Ms. Kunz has a B.S. in Chemistry and in Biology from Thiel College and an M.S. in Polymer Science from the University of Akron and is qualified in the International Executive Program at INSEAD in Fontainebleau, France. She is also certified as a Board Director by the National Association of Corporate Directors.

Positions